BRÈVE

sur EV Nickel Inc. (isin : DE000A3CMGM5)

APONTIS PHARMA Appoints New Head of Supply Chain to Drive Growth

APONTIS PHARMA AG continues its strategic push for growth and internationalization by appointing Mila Brückel as Head of Supply Chain. Brückel brings extensive expertise from her previous roles at Merck Healthcare, where she managed global supply chain programs.

As of 3 June 2024, Brückel is responsible for demand forecasting, procurement, inventory management, new product launches, and distribution at APONTIS PHARMA. She reports directly to CEO Bruno Wohlschlegel.

With over 25 years in supply chain management, including 15 in the pharmaceutical sector, Brückel will help align the company’s product portfolio with market demands and support its international expansion. CEO Wohlschlegel emphasized that her expertise will elevate the company's supply chain operations to a new level.

R. E.

Copyright © 2024 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.

Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève

Voir toutes les actualités de EV Nickel Inc.